Annual CFO
-$18.14 M
-$4.77 M-35.69%
December 31, 2023
Summary
- As of February 8, 2025, CLSD annual cash flow from operations is -$18.14 million, with the most recent change of -$4.77 million (-35.69%) on December 31, 2023.
- During the last 3 years, CLSD annual CFO has fallen by -$5.01 million (-38.22%).
- CLSD annual CFO is now -165.17% below its all-time high of -$6.84 million, reached on December 31, 2013.
Performance
CLSD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$5.91 M
-$233.00 K-4.10%
September 30, 2024
Summary
- As of February 8, 2025, CLSD quarterly cash flow from operations is -$5.91 million, with the most recent change of -$233.00 thousand (-4.10%) on September 30, 2024.
- Over the past year, CLSD quarterly CFO has increased by +$162.00 thousand (+2.67%).
- CLSD quarterly CFO is now -217.00% below its all-time high of $5.05 million, reached on December 31, 2021.
Performance
CLSD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$18.95 M
+$162.00 K+0.85%
September 30, 2024
Summary
- As of February 8, 2025, CLSD TTM cash flow from operations is -$18.95 million, with the most recent change of +$162.00 thousand (+0.85%) on September 30, 2024.
- Over the past year, CLSD TTM CFO has increased by +$5.29 million (+21.82%).
- CLSD TTM CFO is now -9388.73% below its all-time high of $204.00 thousand, reached on June 30, 2022.
Performance
CLSD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CLSD Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -35.7% | +2.7% | +21.8% |
3 y3 years | -38.2% | +2.7% | +21.8% |
5 y5 years | +77.1% | +2.7% | +21.8% |
CLSD Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -69.0% | at low | -217.0% | +24.7% | -9388.7% | +22.5% |
5 y | 5-year | -69.0% | +33.0% | -217.0% | +24.7% | -9388.7% | +30.0% |
alltime | all time | -165.2% | +77.1% | -217.0% | +75.6% | -9388.7% | +76.1% |
Clearside Biomedical Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$5.91 M(+4.1%) | -$18.95 M(-0.8%) |
Jun 2024 | - | -$5.68 M(-27.7%) | -$19.11 M(+1.8%) |
Mar 2024 | - | -$7.85 M(-1686.1%) | -$18.77 M(+3.5%) |
Dec 2023 | -$18.14 M(+35.7%) | $495.00 K(-108.1%) | -$18.14 M(-25.2%) |
Sep 2023 | - | -$6.08 M(+13.8%) | -$24.24 M(-0.5%) |
Jun 2023 | - | -$5.34 M(-26.0%) | -$24.35 M(-0.4%) |
Mar 2023 | - | -$7.22 M(+28.7%) | -$24.45 M(+83.0%) |
Dec 2022 | -$13.37 M(+24.5%) | -$5.61 M(-9.4%) | -$13.37 M(+394.3%) |
Sep 2022 | - | -$6.19 M(+13.7%) | -$2.70 M(-1425.5%) |
Jun 2022 | - | -$5.44 M(-240.6%) | $204.00 K(-115.7%) |
Mar 2022 | - | $3.87 M(-23.4%) | -$1.30 M(-87.9%) |
Dec 2021 | -$10.73 M(-18.2%) | $5.05 M(-254.2%) | -$10.73 M(-46.9%) |
Sep 2021 | - | -$3.28 M(-52.8%) | -$20.22 M(+3.1%) |
Jun 2021 | - | -$6.95 M(+25.0%) | -$19.61 M(+23.5%) |
Mar 2021 | - | -$5.56 M(+25.3%) | -$15.88 M(+21.0%) |
Dec 2020 | -$13.12 M(-51.5%) | -$4.44 M(+66.7%) | -$13.12 M(+87.6%) |
Sep 2020 | - | -$2.66 M(-17.4%) | -$7.00 M(-32.6%) |
Jun 2020 | - | -$3.22 M(+14.9%) | -$10.38 M(-39.7%) |
Mar 2020 | - | -$2.80 M(-266.0%) | -$17.22 M(-36.4%) |
Dec 2019 | -$27.07 M | $1.69 M(-127.9%) | -$27.07 M(-48.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | -$6.05 M(-39.9%) | -$53.02 M(-20.5%) |
Jun 2019 | - | -$10.06 M(-20.5%) | -$66.69 M(-12.5%) |
Mar 2019 | - | -$12.65 M(-47.8%) | -$76.20 M(-3.8%) |
Dec 2018 | -$79.20 M(+55.0%) | -$24.26 M(+23.0%) | -$79.20 M(+13.1%) |
Sep 2018 | - | -$19.72 M(+0.8%) | -$70.03 M(+9.8%) |
Jun 2018 | - | -$19.57 M(+25.0%) | -$63.78 M(+14.4%) |
Mar 2018 | - | -$15.65 M(+3.7%) | -$55.76 M(+9.2%) |
Dec 2017 | -$51.08 M(+124.9%) | -$15.09 M(+12.1%) | -$51.08 M(+20.3%) |
Sep 2017 | - | -$13.46 M(+16.5%) | -$42.45 M(+20.0%) |
Jun 2017 | - | -$11.55 M(+5.2%) | -$35.36 M(+20.7%) |
Mar 2017 | - | -$10.98 M(+70.0%) | -$29.29 M(+29.0%) |
Dec 2016 | -$22.71 M(+63.4%) | -$6.46 M(+1.3%) | -$22.71 M(+13.1%) |
Sep 2016 | - | -$6.37 M(+16.3%) | -$20.08 M(+19.1%) |
Jun 2016 | - | -$5.48 M(+24.7%) | -$16.86 M(+15.9%) |
Mar 2016 | - | -$4.40 M(+14.8%) | -$14.55 M(+4.7%) |
Dec 2015 | -$13.90 M(+52.4%) | -$3.83 M(+21.5%) | -$13.90 M(+38.0%) |
Sep 2015 | - | -$3.15 M(-0.7%) | -$10.07 M(+45.5%) |
Jun 2015 | - | -$3.17 M(-15.3%) | -$6.92 M(+84.7%) |
Mar 2015 | - | -$3.75 M | -$3.75 M |
Dec 2014 | -$9.12 M(+33.4%) | - | - |
Dec 2013 | -$6.84 M | - | - |
FAQ
- What is Clearside Biomedical annual cash flow from operations?
- What is the all time high annual CFO for Clearside Biomedical?
- What is Clearside Biomedical annual CFO year-on-year change?
- What is Clearside Biomedical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Clearside Biomedical?
- What is Clearside Biomedical quarterly CFO year-on-year change?
- What is Clearside Biomedical TTM cash flow from operations?
- What is the all time high TTM CFO for Clearside Biomedical?
- What is Clearside Biomedical TTM CFO year-on-year change?
What is Clearside Biomedical annual cash flow from operations?
The current annual CFO of CLSD is -$18.14 M
What is the all time high annual CFO for Clearside Biomedical?
Clearside Biomedical all-time high annual cash flow from operations is -$6.84 M
What is Clearside Biomedical annual CFO year-on-year change?
Over the past year, CLSD annual cash flow from operations has changed by -$4.77 M (-35.69%)
What is Clearside Biomedical quarterly cash flow from operations?
The current quarterly CFO of CLSD is -$5.91 M
What is the all time high quarterly CFO for Clearside Biomedical?
Clearside Biomedical all-time high quarterly cash flow from operations is $5.05 M
What is Clearside Biomedical quarterly CFO year-on-year change?
Over the past year, CLSD quarterly cash flow from operations has changed by +$162.00 K (+2.67%)
What is Clearside Biomedical TTM cash flow from operations?
The current TTM CFO of CLSD is -$18.95 M
What is the all time high TTM CFO for Clearside Biomedical?
Clearside Biomedical all-time high TTM cash flow from operations is $204.00 K
What is Clearside Biomedical TTM CFO year-on-year change?
Over the past year, CLSD TTM cash flow from operations has changed by +$5.29 M (+21.82%)